CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 2.530
- +0.040+1.61%
Close Apr 29 16:00 ET
- 2.710
- +0.180+7.11%
Pre 08:00 ET
75.30MMarket Cap-4.56P/E (TTM)
2.590High2.440Low171.18KVolume2.470Open2.490Pre Close433.51KTurnover0.98%Turnover RatioLossP/E (Static)29.76MShares8.40052wk High115.00P/B44.19MFloat Cap2.35452wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM6.02%Amplitude2.354Historical Low2.532Avg Price1Lot Size
Telomir Pharmaceuticals News
Telomir Pharmaceuticals Announces Preclinical Findings on Telomir-1
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
Express News | Telomir Pharmaceuticals Says 'Telomir-1 Alone at Both Low and High Doses Reduced Tumor Growth by Approximately 50%'
Express News | Telomir Pharmaceuticals Says 'Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity'
Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
Express News | Telomir Pharmaceuticals - Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Calcium Dysregulation in Multiple Human Cell Lines
Rodman & Renshaw Initiates Telomir Pharmaceuticals(TELO.US) With Buy Rating, Announces Target Price $15
Telomir Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
Express News | Telomir Pharmaceuticals Achieves Breakthrough In Silver Ion Stabilization, Says Unlocking A New Multi-Billion Dollar Medical Market
Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Express News | Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing
Telomir Pharmaceuticals | 10-K: FY2024 Annual Report
Telomir Pharmaceuticals Announces Results From Preclinical Studies of Telomir-1
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Touts Potential of Telomir-1 in Addressing Oxidative Stress
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025